OPEN END TURBO OPTIONSSCHEIN LONG - ABBOTT LABORATORIES Stock

Certificat

DE000GQ917H5

Real-time BOERSE MUENCHEN 02:26:44 2024-06-14 pm EDT
0.356 EUR +2.89% Intraday chart for OPEN END TURBO OPTIONSSCHEIN LONG - ABBOTT LABORATORIES
Current month+70.33%
1 month-19.64%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-14 0.356 +2.89%
24-06-13 0.346 -28.22%
24-06-12 0.482 -17.89%
24-06-11 0.587 -23.87%
24-06-10 0.771 +6.93%

Real-time BOERSE MUENCHEN

Last update June 14, 2024 at 02:26 pm EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer Goldman Sachs
WKN GQ917H
ISINDE000GQ917H5
Date issued 2023-11-15
Strike 99.88 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.2
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.164
Lowest since issue 0.16
Spread 0.02
Spread %5.12%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103.7 USD
Average target price
125.4 USD
Spread / Average Target
+20.92%
Consensus